September 9, 2016
6701 Rockledge Drive, (Conference Room 9100/9104) Bethesda, MD 20892
The severe anemia associated with hematologic disorders such as β thalassemia, myelodysplastic syndrome, and congenital dyserythropoietic anemia, arises from defects in late stage erythroid maturation (dyserythropoiesis). In contrast to anemias resulting from early stage defects, this group of disorders are resistant to erythropoietin (EPO) therapy since late-stage erythroblast differentiation and maturation is EPO independent. Transfusion, often associated with iron overload and alloimmunization, remains the principal approach to care. Fortunately, however, several molecular determinants of dyserythropoiesis have been recently identified. It is possible that these discoveries may reveal common pathways leading to dyserythropoiesis. This workshop will consider the gaps in our knowledge and technology that are barriers to our understanding of the underlying biologies that may lead to effective new treatments for late stage erythroid maturation defects. This workshop will also provide an opportunity for the research community to cooperatively consider the essential next steps for the field.
September 26, 2016 to September 27, 2016
This workshop has two main objectives: (a) to assess recent developments in statistical methods relevant to NHLBI studies; (b) to identify the major challenges and important issues related to these statistical and analytical methods.
October 24, 2016 to October 25, 2016
Natcher Conference Center(Building 45) Bethesda, Maryland
The conference Unraveling Vascular Inflammation: From Immunology to Imaging 2016, sponsored by the National Heart, Lung and Blood Institutes (NHLBI) of the National Institutes of Health (NIH), seeks to convene scientists, researchers and physicians from around the world with an interest in immunology, human translational studies involving cardiovascular imaging and quantification. Hosted at the NIH campus, in Bethesda, MD, October 24 and 25, the day and a half conference will feature three keynote speakers (immunology, human inflammation and imaging), poster session and competition (including cash poster award and A High-Yield Series of Imaging Talks, a rapid fire series of 10 minutes talks by leading imaging scientists in the field.
November 1, 2016 to November 3, 2016
NHLBI Innovation Conference NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts the NHLBI Innovation Conference to connect NHLBI-funded companies with investors, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries.